Strides Pharma Science to get $20 mn funding for consumer healthcare biz

"Board of directors have approved the execution by Strides of definitive agreements with funds advised by ICP-III Investment Advisors (ICP) to provide growth capital and focused attention to its Consumer Healthcare Business (CHC)," Strides Pharma Science said in a BSE filing and added that ICP would provide the business with a USD 20 million capital for growth.

from Moneycontrol Business News https://ift.tt/2zc0g6w